LASEZKAY GEORGE M 4
4 · Clearside Biomedical, Inc. · Filed Mar 13, 2020
Insider Transaction Report
Form 4
LASEZKAY GEORGE M
DirectorCEO
Transactions
- Award
Common Stock
2020-03-11+50,000→ 343,250 total
Footnotes (2)
- [F1]These shares are represented by restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock of the Issuer. The shares underlying the RSU vest in two equal annual installments on each of February 28, 2021 and February 28, 2022, subject to the Reporting Person's continuous service as of each such vesting date, and subject to accelerated vesting in specified circumstances.
- [F2]Includes 5,000 shares acquired under the Issuer's employee stock purchase plan on December 31, 2019.